Patent US4416988A successfully refreshed from Google Patents.
US4416988A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Detection and isolation of enkephalin mRNA using a synthetic oligodeoxynucleotide
Assignee: Individual
•
Filing: 1982-09-17
•
Granted: 1983-11-22
•
Expires: 2002-09-17
Abstract
Abstract A synthetic oligodeoxynucleotide complementary to endorphin mRNA and a method of using it to detect and isolate endorphin mRNA and cDNA from human and rabbit pancreas. A unique 15 base oligodeoxynucleotide dCATGAACCCGCCGTA wherein T represents thymine, G represents guanine, A represents adenine, and C represents cytosine and where at least 13 of the 15 nucleotides are as indicated (one of those indicated may be instead one of the other three mentioned nucleotides) has been found to be complementary to endorphin mRNA. To isolate endorphin mRNA, total RNA is first extracted from human brain and A+ is isolated from the total RNA. Other tissues may be used. The A+ RNA is then treated with the oligodeoxynucleotide, and the resulting hybridized RNA is enzymatically converted to endorphin mRNA:cDNA which can then be purified and used in a conventional manner to produce endorphin by cloning techniques.
Inventors
- 👤 Harvey Rubin
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 05:26
CPC Classifications
C; C07; C07H; C07H21/00; C07K; C07K14/00; C07K14/435; C07K14/665; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
103 words
The method of isolating endorphin mRNA:cDNA from pancreas, brain, adrenal and pituitary tissue which comprises the steps of: extracting total RNA from brain, adrenal, pancreas or pituitary tissue; isolating A+ RNA from said total RNA; hybridizing under suitable conditions and temperatures said A+ RNA with a 15 base oligodeoxynucleotide CATxAAyCCyCCGTA, wherein "A" represents adenine, "T" represents thymine, "G" represents guanine, "C" represents cytosine, "x" represents guanine or adenine and "y" represents guanine, thymine, cytosine or adenine; copying the hybridized endorphin mRNA into complementary DNA; and isolating said complementary DNA, whereby substantially only endorphin mRNA:cDNA remains, substantially all other RNA fractions having been removed.
Claim 2
Independent Claim
103 words
The method of isolating endorphin mRNA:cDNA from pancreas, brain, adrenal and pituitary tissue which comprises the steps of: extracting total RNA from brain, adrenal, pancreas or pituitary tissue; isolating A+ RNA from said total RNA; hybridizing under suitable conditions and temperatures said A+ RNA with a 15 base oligodeoxynucleotide CATxAAyCCyCCGTA, wherein "A" represents adenine, "T" represents thymine, "G" represents guanine, "C" represents cytosine, "x" represents guanine or adenine and "y" represents guanine, thymine, cytosine or adenine; copying the hybridized endorphin mRNA into complementary DNA; and isolating said complementary DNA, whereby substantially only endorphin mRNA:cDNA remains, substantially all other RNA fractions having been removed.
Claim 3
Dependent Claim
13 words
The method according to claim 1, wherein said oligodeoxynucleotide has the sequence CATGAACCCGCCGTA.
Claim 4
Dependent Claim
18 words
The method according to claim 1 wherein said hybridization temperature range is from about 0° to 40° C.
Claim 5
Independent Claim
109 words
The method of isolating endorphin mRNA:cDNA which comprises the steps of: extracting total RNA from human tissue selected from the group consisting of brain, adrenal, pituitary and pancreas tissue and mixtures thereof; isolating A+ RNA from said total; simultaneously hybridizing said A+ RNA with two 15 base oligodeoxynucleotides which bind to endorphin mRNA at separate chain locations, said oligodeoxynucleotides selected from the group consisting of CATGAACCCGCCGTA and CTGGCCTTTTTTGTG, wherein "A" represents adenine, "T" represents thymine "G" represents guanine and "C" represents cytosine; copying the hybridized endorphin mRNA into complementary DNA; and isolating said complementary DNA, whereby substantially only endorphin mRNA:cDNA remains, substantially all other RNA fractions having been removed.
Claim 6
Independent Claim
109 words
The method of isolating endorphin mRNA:cDNA which comprises the steps of: extracting total RNA from human tissue selected from the group consisting of brain, adrenal, pituitary and pancreas tissue and mixtures thereof; isolating A+ RNA from said total; simultaneously hybridizing said A+ RNA with two 15 base oligodeoxynucleotides which bind to endorphin mRNA at separate chain locations, said oligodeoxynucleotides selected from the group consisting of CATGAACCCGCCGTA and CTGGCCTTTTTTGTG, wherein "A" represents adenine, "T" represents thymine "G" represents guanine and "C" represents cytosine; copying the hybridized endorphin mRNA into complementary DNA; and isolating said complementary DNA, whereby substantially only endorphin mRNA:cDNA remains, substantially all other RNA fractions having been removed.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-11-21 | 1987-05-23 | 1987-11-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-11-21 | 1991-05-23 | 1991-11-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-11-21 | 1995-05-23 | 1995-11-22 | $7700.00 | Window Closed / Lapsed |